A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8

The entire envelope gene of a British HIV-1 isolate, GB8, was cloned, sequenced and aligned with those of the reference strains MN, SF2 and IIIB LAI . Three of the viruses (MN, IIIB LAI , GB8) and their recombinant gp120s, were then characterised using an extensive panel of human HIV-1 positive sera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 1995, Vol.13 (8), p.735-741
Hauptverfasser: Vella, Cherelyn, Smith, Marion H, Farrar, Graham H, Jones, David H, Daniels, Rodney S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 741
container_issue 8
container_start_page 735
container_title Vaccine
container_volume 13
creator Vella, Cherelyn
Smith, Marion H
Farrar, Graham H
Jones, David H
Daniels, Rodney S
description The entire envelope gene of a British HIV-1 isolate, GB8, was cloned, sequenced and aligned with those of the reference strains MN, SF2 and IIIB LAI . Three of the viruses (MN, IIIB LAI , GB8) and their recombinant gp120s, were then characterised using an extensive panel of human HIV-1 positive sera and mapped neutralising monoclonal antibodies (MAbs). Overall, the GB8 env-gene translation product shares 84% homology with those of the reference strains. Across the V3 region homology was greater between GB8 and SF2 MN (74.3–88.6%) than IIIB LAI (63.9–66.7%). Accordingly, GB8 was sensitive to V3-specific MAbs which neutralise MN SF2 and resistant to those that neutralize IIIB LAI . In the CD4 binding region the central MWQEVGKAMYAPPI was conserved in all viruses but homology in the N-terminus was greater between GB8 and SF2 and IIIB LAI than MN. GB8 and IIIB LAI were sensitive to all MAbs raised against the CD4 binding site whereas MN was resistant to 3 of 4 tested. Human sera obtained from a London-based cohort did not differentiate between GB8 and MN in neutralisation assays, whereas IIIB LAI titres were significantly lower at all stages of disease. These results show that GB8 carries a consensus-like V3 loop and is as representative as MN of HIV-1 viruses circulating in the UK. To our knowledge, GB8 is the only British HIV-1 isolate which has been characterised to date.
doi_str_mv 10.1016/0264-410X(94)00048-R
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77744856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0264410X9400048R</els_id><sourcerecordid>16863450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-914ee08275071369afbff27fdfc6c8e05d355769a1d10f1a19ee3c07bf2dbb1c3</originalsourceid><addsrcrecordid>eNqFkNFKHDEUhkOp2NX2DVrIRSn2YmrOJDPJ9KKg0qogCNJK70ImOdFIdrJNZgTfvrPddS_t1YFzvvPz8xHyHtgXYNAes7oVlQD2-6gTnxljQlU3r8gClORV3YB6TRY75A05KOVhhhoO3T7Zl0JxqdSC3J7QZYpop2gyNYOjBXOK6S5YWsbJPdHk6XiPFIdHjGmF9A4HfF6e5jCGck9DSdGM-JVeXN5WQM9P1Vuy500s-G47D8mvH99_nl1UV9fnl2cnV5UVIMeqA4HIVC0bJoG3nfG997X0ztvWKmSN400j5z04YB4MdIjcMtn72vU9WH5IPm1yVzn9mbCMehmKxRjNgGkqWkophGra_4LQqpaLhs2g2IA2p1Iyer3KYWnykwam1971WqpeS9Wd0P-865v57cM2f-qX6HZPW9Hz_eP2boo10Wcz2FB2GGcwV-Uz9m2D4SztMWDWxQYcLLqQ0Y7apfByj79oqJ2B</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16863450</pqid></control><display><type>article</type><title>A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Vella, Cherelyn ; Smith, Marion H ; Farrar, Graham H ; Jones, David H ; Daniels, Rodney S</creator><creatorcontrib>Vella, Cherelyn ; Smith, Marion H ; Farrar, Graham H ; Jones, David H ; Daniels, Rodney S</creatorcontrib><description>The entire envelope gene of a British HIV-1 isolate, GB8, was cloned, sequenced and aligned with those of the reference strains MN, SF2 and IIIB LAI . Three of the viruses (MN, IIIB LAI , GB8) and their recombinant gp120s, were then characterised using an extensive panel of human HIV-1 positive sera and mapped neutralising monoclonal antibodies (MAbs). Overall, the GB8 env-gene translation product shares 84% homology with those of the reference strains. Across the V3 region homology was greater between GB8 and SF2 MN (74.3–88.6%) than IIIB LAI (63.9–66.7%). Accordingly, GB8 was sensitive to V3-specific MAbs which neutralise MN SF2 and resistant to those that neutralize IIIB LAI . In the CD4 binding region the central MWQEVGKAMYAPPI was conserved in all viruses but homology in the N-terminus was greater between GB8 and SF2 and IIIB LAI than MN. GB8 and IIIB LAI were sensitive to all MAbs raised against the CD4 binding site whereas MN was resistant to 3 of 4 tested. Human sera obtained from a London-based cohort did not differentiate between GB8 and MN in neutralisation assays, whereas IIIB LAI titres were significantly lower at all stages of disease. These results show that GB8 carries a consensus-like V3 loop and is as representative as MN of HIV-1 viruses circulating in the UK. To our knowledge, GB8 is the only British HIV-1 isolate which has been characterised to date.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/0264-410X(94)00048-R</identifier><identifier>PMID: 7483788</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>AIDS/HIV ; Amino Acid Sequence ; Antibodies, Monoclonal - pharmacology ; Antigen-Antibody Reactions ; Base Sequence ; Biological and medical sciences ; CD4 binding site ; Cells, Cultured ; Fundamental and applied biological sciences. Psychology ; GB8 rgp120 ; Genes, env ; HIV Envelope Protein gp120 - genetics ; HIV Envelope Protein gp120 - immunology ; HIV Seropositivity - immunology ; HIV-1 - genetics ; HIV-1 - immunology ; HIV-1 - isolation &amp; purification ; HIV-1GB8 British isolate sequence ; human immunodeficiency virus 1 ; Humans ; Immune Sera - pharmacology ; Microbiology ; Molecular Sequence Data ; Morphology, structure, chemical composition, physicochemical properties ; neutralisation V3 ; Neutralization Tests ; Peptides - immunology ; Recombinant Proteins - immunology ; serology ; United Kingdom ; Virology</subject><ispartof>Vaccine, 1995, Vol.13 (8), p.735-741</ispartof><rights>1995</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-914ee08275071369afbff27fdfc6c8e05d355769a1d10f1a19ee3c07bf2dbb1c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0264-410X(94)00048-R$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,4024,27923,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3017773$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7483788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vella, Cherelyn</creatorcontrib><creatorcontrib>Smith, Marion H</creatorcontrib><creatorcontrib>Farrar, Graham H</creatorcontrib><creatorcontrib>Jones, David H</creatorcontrib><creatorcontrib>Daniels, Rodney S</creatorcontrib><title>A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>The entire envelope gene of a British HIV-1 isolate, GB8, was cloned, sequenced and aligned with those of the reference strains MN, SF2 and IIIB LAI . Three of the viruses (MN, IIIB LAI , GB8) and their recombinant gp120s, were then characterised using an extensive panel of human HIV-1 positive sera and mapped neutralising monoclonal antibodies (MAbs). Overall, the GB8 env-gene translation product shares 84% homology with those of the reference strains. Across the V3 region homology was greater between GB8 and SF2 MN (74.3–88.6%) than IIIB LAI (63.9–66.7%). Accordingly, GB8 was sensitive to V3-specific MAbs which neutralise MN SF2 and resistant to those that neutralize IIIB LAI . In the CD4 binding region the central MWQEVGKAMYAPPI was conserved in all viruses but homology in the N-terminus was greater between GB8 and SF2 and IIIB LAI than MN. GB8 and IIIB LAI were sensitive to all MAbs raised against the CD4 binding site whereas MN was resistant to 3 of 4 tested. Human sera obtained from a London-based cohort did not differentiate between GB8 and MN in neutralisation assays, whereas IIIB LAI titres were significantly lower at all stages of disease. These results show that GB8 carries a consensus-like V3 loop and is as representative as MN of HIV-1 viruses circulating in the UK. To our knowledge, GB8 is the only British HIV-1 isolate which has been characterised to date.</description><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antigen-Antibody Reactions</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>CD4 binding site</subject><subject>Cells, Cultured</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GB8 rgp120</subject><subject>Genes, env</subject><subject>HIV Envelope Protein gp120 - genetics</subject><subject>HIV Envelope Protein gp120 - immunology</subject><subject>HIV Seropositivity - immunology</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - immunology</subject><subject>HIV-1 - isolation &amp; purification</subject><subject>HIV-1GB8 British isolate sequence</subject><subject>human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Immune Sera - pharmacology</subject><subject>Microbiology</subject><subject>Molecular Sequence Data</subject><subject>Morphology, structure, chemical composition, physicochemical properties</subject><subject>neutralisation V3</subject><subject>Neutralization Tests</subject><subject>Peptides - immunology</subject><subject>Recombinant Proteins - immunology</subject><subject>serology</subject><subject>United Kingdom</subject><subject>Virology</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkNFKHDEUhkOp2NX2DVrIRSn2YmrOJDPJ9KKg0qogCNJK70ImOdFIdrJNZgTfvrPddS_t1YFzvvPz8xHyHtgXYNAes7oVlQD2-6gTnxljQlU3r8gClORV3YB6TRY75A05KOVhhhoO3T7Zl0JxqdSC3J7QZYpop2gyNYOjBXOK6S5YWsbJPdHk6XiPFIdHjGmF9A4HfF6e5jCGck9DSdGM-JVeXN5WQM9P1Vuy500s-G47D8mvH99_nl1UV9fnl2cnV5UVIMeqA4HIVC0bJoG3nfG997X0ztvWKmSN400j5z04YB4MdIjcMtn72vU9WH5IPm1yVzn9mbCMehmKxRjNgGkqWkophGra_4LQqpaLhs2g2IA2p1Iyer3KYWnykwam1971WqpeS9Wd0P-865v57cM2f-qX6HZPW9Hz_eP2boo10Wcz2FB2GGcwV-Uz9m2D4SztMWDWxQYcLLqQ0Y7apfByj79oqJ2B</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>Vella, Cherelyn</creator><creator>Smith, Marion H</creator><creator>Farrar, Graham H</creator><creator>Jones, David H</creator><creator>Daniels, Rodney S</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>1995</creationdate><title>A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8</title><author>Vella, Cherelyn ; Smith, Marion H ; Farrar, Graham H ; Jones, David H ; Daniels, Rodney S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-914ee08275071369afbff27fdfc6c8e05d355769a1d10f1a19ee3c07bf2dbb1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antigen-Antibody Reactions</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>CD4 binding site</topic><topic>Cells, Cultured</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GB8 rgp120</topic><topic>Genes, env</topic><topic>HIV Envelope Protein gp120 - genetics</topic><topic>HIV Envelope Protein gp120 - immunology</topic><topic>HIV Seropositivity - immunology</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - immunology</topic><topic>HIV-1 - isolation &amp; purification</topic><topic>HIV-1GB8 British isolate sequence</topic><topic>human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Immune Sera - pharmacology</topic><topic>Microbiology</topic><topic>Molecular Sequence Data</topic><topic>Morphology, structure, chemical composition, physicochemical properties</topic><topic>neutralisation V3</topic><topic>Neutralization Tests</topic><topic>Peptides - immunology</topic><topic>Recombinant Proteins - immunology</topic><topic>serology</topic><topic>United Kingdom</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vella, Cherelyn</creatorcontrib><creatorcontrib>Smith, Marion H</creatorcontrib><creatorcontrib>Farrar, Graham H</creatorcontrib><creatorcontrib>Jones, David H</creatorcontrib><creatorcontrib>Daniels, Rodney S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vella, Cherelyn</au><au>Smith, Marion H</au><au>Farrar, Graham H</au><au>Jones, David H</au><au>Daniels, Rodney S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>1995</date><risdate>1995</risdate><volume>13</volume><issue>8</issue><spage>735</spage><epage>741</epage><pages>735-741</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>The entire envelope gene of a British HIV-1 isolate, GB8, was cloned, sequenced and aligned with those of the reference strains MN, SF2 and IIIB LAI . Three of the viruses (MN, IIIB LAI , GB8) and their recombinant gp120s, were then characterised using an extensive panel of human HIV-1 positive sera and mapped neutralising monoclonal antibodies (MAbs). Overall, the GB8 env-gene translation product shares 84% homology with those of the reference strains. Across the V3 region homology was greater between GB8 and SF2 MN (74.3–88.6%) than IIIB LAI (63.9–66.7%). Accordingly, GB8 was sensitive to V3-specific MAbs which neutralise MN SF2 and resistant to those that neutralize IIIB LAI . In the CD4 binding region the central MWQEVGKAMYAPPI was conserved in all viruses but homology in the N-terminus was greater between GB8 and SF2 and IIIB LAI than MN. GB8 and IIIB LAI were sensitive to all MAbs raised against the CD4 binding site whereas MN was resistant to 3 of 4 tested. Human sera obtained from a London-based cohort did not differentiate between GB8 and MN in neutralisation assays, whereas IIIB LAI titres were significantly lower at all stages of disease. These results show that GB8 carries a consensus-like V3 loop and is as representative as MN of HIV-1 viruses circulating in the UK. To our knowledge, GB8 is the only British HIV-1 isolate which has been characterised to date.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>7483788</pmid><doi>10.1016/0264-410X(94)00048-R</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 1995, Vol.13 (8), p.735-741
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_77744856
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects AIDS/HIV
Amino Acid Sequence
Antibodies, Monoclonal - pharmacology
Antigen-Antibody Reactions
Base Sequence
Biological and medical sciences
CD4 binding site
Cells, Cultured
Fundamental and applied biological sciences. Psychology
GB8 rgp120
Genes, env
HIV Envelope Protein gp120 - genetics
HIV Envelope Protein gp120 - immunology
HIV Seropositivity - immunology
HIV-1 - genetics
HIV-1 - immunology
HIV-1 - isolation & purification
HIV-1GB8 British isolate sequence
human immunodeficiency virus 1
Humans
Immune Sera - pharmacology
Microbiology
Molecular Sequence Data
Morphology, structure, chemical composition, physicochemical properties
neutralisation V3
Neutralization Tests
Peptides - immunology
Recombinant Proteins - immunology
serology
United Kingdom
Virology
title A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A45%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20molecular%20and%20serologic%20study%20of%20the%20envelope%20gene%20of%20the%20British%20isolate:%20HIV-1%20GB8&rft.jtitle=Vaccine&rft.au=Vella,%20Cherelyn&rft.date=1995&rft.volume=13&rft.issue=8&rft.spage=735&rft.epage=741&rft.pages=735-741&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/0264-410X(94)00048-R&rft_dat=%3Cproquest_cross%3E16863450%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16863450&rft_id=info:pmid/7483788&rft_els_id=0264410X9400048R&rfr_iscdi=true